The global in-vitro fertilization (IVF) market is projected to reach USD 27 billion by 2022, according to a report by Grand View Research, Inc. It had a valuation of around USD 14.1 billion in 2016. Factors driving the market include rising cases of infertility, development of advanced fertility procedures such as intracytoplasmic sperm injection (ICSI), availability of reimbursement policies, and continuous efforts by industry players.
Availability of genomic testing to discern the probability of genetic diseases during IVF can bolster market growth from 2012 to 2022 (forecast period). Development of advanced technologies like lensless imaging can positively influence growth of the in-vitro fertilization market in near future. Increased average age of marriage and its connection to fertility are expected to augur demand for IVF over the forecast period. Government-funded programs to encourage cryopreservation of sperm and eggs coupled with technological advances to treat infertility among couples can positively impact the market. In April 2016, CombiMatrix Corporation introduced the Combi Preimplantation Genetic Diagnosis (PGD), a diagnostic procedure to detect genetic disorders prior to IVF treatment.
The worldwide in-vitro fertilization (IVF) market is segmented according to cycle, instrument, procedure, and region. By cycle, the market is divided into fresh donor, frozen donor, fresh non-donor, and frozen non-donor. The fresh non-donor segment accounted for large market share owing to its high success rate. The frozen non-donor segment, on the other hand, is anticipated to experience a robust growth rate over the forecast period.
Full Research Report On IVF Market Analysis: https://www.grandviewresearch.com/industry-analysis/in-vitro-fertilization-market
Key instrument segments within the market are categorized into culture media, capital equipment, and IVF disposable devices. Culture media was the dominant segment, in terms of revenue, in 2014. Increasing demand for cryopreservation and rise in government funding are factors expected to drive segment growth in near future.
Major procedures are divided into pre-implantation genetic diagnosis (PGD), frozen embryo replacement (FER), intracytoplasmic sperm injection (ICSI), and others. In 2014, the ICSI segment had dominated the IVF market in 2014 owing to its stupendous success rate. The procedures played a major role in delivering a baby from a frozen egg in Nigeria in April 2016. The FER segment is estimated to experience rapid rise in demand in the forthcoming years.
Regions covered in the market report include Latin America, North America, Asia Pacific (APAC), Middle East & Africa (MEA), and Europe. The Europe in-vitro fertilization market had dominated in 2014 owing to legal approval of the three-parent baby technique. Innovations in IVF procedures is also one of the major regional market drivers. Thriving medical tourism in the region, availability of high-quality treatment at affordable prices, and strict adherence to safety standards are other driving factors for the market. Germany, France, and the U.K. are three major revenue contributors for the IVF market owing to efficacy of treatment and the provision of legal citizenship to surrogate children.
View More Reports Of This Category By Grand View Research At: https://www.grandviewresearch.com/industry/medical-devices
The North America market for in-vitro fertilization held a significant market share in 2014 owing to regulatory reforms regarding IVF treatment. Furthermore, introduction of advanced IVF procedures, government funding for egg/sperm storage, and standardization of procedures via automation are expected to boost regional market during the forecast period. Rise in number of clinics offering male fertility treatments and favorable reimbursement policies outlined by the U.S. Department of Defense can further drive regional market growth over the forecast period.
The APAC IVF market is expected an upsurge over the forecast period owing to growing medical tourism and number of companies attempting to establish their brand in the region. Equity investments by reputed firms in domestic chains and changing regulations are projected to bode well for the market. The Japan market possess growth potential owing to establishment of non-profit organizations to accumulate oocytes for female reproduction. Initiatives which create awareness such as the Asia Pacific Initiative on Reproduction (ASPIRE) on assistive reproductive techniques (ART) can be instrumental in inducing demand. Ban on surrogacy can also influence market demand in the forthcoming years.
Prominent IVF market players include Cook Medical Inc.; Boston IVF; Thermo Fisher Scientific Inc.; EMD Serono Inc.; and Genea Biomedx. Development of breakthrough products and transition to IVF treatments from invasive to minimally invasive are strategies expected to bode well for these players. New technologies to assist older women in bearing children are likely to augur market growth. For instance, in 2015, OvaScience, a U.S. based company, published results of its proprietary product, AUGMENT. According to these results, the product enjoyed a higher success rate than conventional treatments.
Access Full Press Release Of This Report By Grand View Research: https://www.grandviewresearch.com/press-release/global-ivf-market
About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.
For more information: www.grandviewresearch.com
Company Name: Grand View Research, Inc.
Contact Person: Sherry James, Corporate Sales Specialist – U.S.A.
Email: Send Email
Phone: 1-415-349-0058, Toll Free: 1-888-202-9519
Address:28 2nd Street, Suite 3036
City: San Francisco
Country: United States